Power ML, Schulkin J
As of July 12, 2026, COVID test positivity nationally stood at 4.8%, up 1.1% from the previous week
These recommendations are based on results that showed that GLP-1RA compared with insulin therapy (basal, premixed, or intensified basal-bolus regimens) have similar or even better efficacy in HbA1c reduction and a lower hypoglycemia risk, promotes weight loss instead of weight gain, and reduces the burden of drug administration frequency and self-monitoring of blood glucose [1, 2]
PubMed Ugwu SO, Blanchard J, Dorr RT, Levine N, Brooks C, Hadley ME, et al
Clinical trials further support these conclusions